SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000950103-22-015344
Filing Date
2022-09-06
Accepted
2022-09-06 16:41:32
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 dp179924_f3-2.htm F-3 351423
2 EXHIBIT 4.1 dp179924_ex0401.htm EX-4.1 307541
3 EXHIBIT 5.1 dp179924_ex0501.htm EX-5.1 24771
4 EXHIBIT 23.1 dp179924_ex2301.htm EX-23.1 2019
5 EXHIBIT 107 dp179924_exfillingfee.htm EX-FILING FEES 32709
6 GRAPHIC image_001.jpg GRAPHIC 4229
7 GRAPHIC image_002.jpg GRAPHIC 4228
  Complete submission text file 0000950103-22-015344.txt   731373
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-267295 | Film No.: 221228742
SIC: 2834 Pharmaceutical Preparations